Ophidion, Inc.

OPHIDION, INC. is developing a new class of safe and effective drugs targeting some of the most important receptors in the central nervous system. It is targeting relief of the symptoms of schizophrenia, ADHD, Parkinson’s disease, and Alzheimer’s disease as well as addiction and anxiety. The founder launched the company in the Pasadena Bioscience Collaborative and relocated to TechVentures.